0.23600000 USD
0.006
2.61%
Last update Dec 12, 3:58 PM EST
Market closed
Day range
0.23150000
0.24500000
Previous close
0.23000000
Open
0.23250000
Access this stock data via API
Subscribe
Northwest Biotherapeutics Inc.
0.24
0.01
2.61%

Financials

Income statement

Fiscal date Sep 2025 Jun 2025 Mar 2025 Dec 2024
Total reported revenue 200K 131K 375K 231K
Cost of revenue
Gross profit
Operating expense
Research & development 7.5M 7.4M 8.4M 10.5M
Selling general and admin 7.1M 7.5M 9.3M 8.2M
Other operating expenses
Operating income -14.3M -14.8M -17.3M -18.5M
Non operating interest income
Income
Expense 2.6M 1.8M 1.6M 2.5M
Other income expense -9.9M 1.2M -430K -7.2M
Pretax income -26.8M -15.4M -19.3M -28.2M
Tax provision
Net income -26.8M -15.4M -19.3M -28.2M
Basic EPS 0.0 0.0 0.0
Diluted EPS 0.0 0.0 0.0
Basic average shares 1.5B 1.4B 1.4B
Diluted average shares 1.5B 1.4B 1.4B
EBITDA -15.4M -15.3M -16.8M -18.8M
Net income from continuing op. -26.8M -15.4M -19.3M -28.2M
Minority interests
Preferred stock dividends 353K 560K 265K 273K
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Market closed

Exchange is currently closed (non-working day)
Pre-market opens in 6 hours 30 minutes

23:29
00:00
23:59

Trading Hours (Monday - Friday):

Pre-market
06:00 - 09:30
Main market
09:30 - 16:00
Post-market
16:00 - 17:00
All times are displayed in the America/New_York timezone (EST, UTC-05:00).